This innovation deals with adverse effects of Mn nanoparticles on brain pathology in concussive head injury. Also Mn nanoparticles treatment alters therapeutic modalities. The novel data presented in the abstract show that Mn exposure to our military personal from various industries, welding or deep mine work could make them more vulnerable to any additional head injury. This work also for the first time showed that neuroprotective agents in Mn treated traumatized group require in high concentration to treat effectively the brain pathologies. These data are strategically very important for further development of industrial or military medicine for health benefits. Furthermore, we have shown that nanowired delivery of 5-HT2 receptor antagonists e.g., ketanserin and ritanserin remarkably attenuated exacerbation of brain pathology after CHI in MN NPs treated group, not reported earlier.
Journal: TechConnect Briefs
Volume: 3, Biotech, Biomaterials and Biomedical: TechConnect Briefs 2015
Published: June 14, 2015
Pages: 37 - 40
Industry sectors: Advanced Materials & Manufacturing | Medical & Biotech
Topics: Biomaterials, Materials for Drug & Gene Delivery